Hyperhidrosis is a condition where in a person experiences an excessive sweating. It mainly affects the facial area, hands, feet, and armpit. The sweating is either localized, i.e., the sweating will occur in a particular area or generalized. It further has two subtypes – primary axillary hyperhidrosis and secondary generalized hyperhidrosis. Some of the symptoms for hyperhidrosis include wet feet, palms or soles and frequent sweating. Hyperhidrosis is present since the time of birth or it develops later. Severe consequences of it may lead to bacterial or fungal infections. Causes of hyperhidrosis include heart disease, anxiety disorder, obesity, infectious diseases including malaria, tuberculosis, etc.
Global Hyperhidrosis Treatment Market Drivers
Key players are focused on developing new products for the treatment of hyperhidrosis, which is expected to boost the global hyperhidrosis treatment market growth. For instance, in October 2018, Dermira Inc., launched Qbrexa cloth for the treatment of primary axillary hyperhidrosis. It contains anti-cholinergic drug, glycopyrronium and is designed for adults as well as pediatrics (aged 9 years and above). It received the U.S. Food & Drug Administration approval in June, 2018.
Furthermore, in December 2016, GlaxoSmithKline completed its phase II clinical trials study of Umeclidinium for the treatment of hyperhidrosis. The purpose of the study was to evaluate the efficacy, pharmacokinetics, and tolerability of the drug in the patients with primary axillary hyperhidrosis. The study revealed that on the 15th day of the treatment, minimum 50% of sweat reduction was observed in around in seven patients. Hence, such developments are expected to fuel growth of global hyperhidrosis treatment market over the forecast period.
Adoption of strategies such as mergers, acquisitions, and collaborations by key players is expected to drive the global hyperhidrosis market growth. For instance, in April 2015, Brickell Biotech Inc., a clinical-stage pharmaceutical company entered into an agreement with Kaken Pharmaceutical Co., Ltd., a pharmaceutical company for the development of BBI-4000. It is a topical anticholinergic used for the treatment of hyperhidrosis. Hence, such agreements are expected to propel the global hyperhidrosis market growth.
Global Hyperhidrosis Treatment Market Regional Analysis
North America is expected to hold a dominant position in the global hyperhidrosis market due to presence of key players such as Brickell Biotech Inc., Dermira Inc., and others. These key players are focused on adapting growth strategies such as mergers, acquisitions, partnership, collaboration, etc. For instance, in June 2019, Brickell Biotech, Inc., a clinical stage pharmaceutical company merged with Vical Inc., a biopharmaceutical company. The aim of the merger was for developing novel approaches to treat hyperhidrosis and other dermatological disorders.
Furthermore, Asia Pacific is expected to witness significant growth in the global hyperhidrosis treatment market, owing to increasing prevalence of hyperhidrosis in the region. According to the Department of Dermatology, Government Medical College (India) data of 2018, around 320 cases (out of 10,000) were diagnosed with hyperhidrosis. Hence higher prevalence of hyperhidrosis may lead to increase in demand for the treatment, which is expected to support the global hyperhidrosis treatment market growth.
Global Hyperhidrosis Treatment Market Restraints
Side effects of drugs may hamper the global hyperhidrosis treatment market growth. For instance, drystol is a topical treatment of hyperhidrosis, which includes side effects such as mild itching, burning, allergic reactions, severe burning, dizziness, and swelling on the applied area. Hence, such side effects of drugs may obstruct the global hyperhidrosis treatment market growth.
Global Hyperhidrosis Treatment Market Key Players
Some of the major players operating in the global hyperhidrosis treatment market include, Allergan plc, Theravida Inc., GlaxoSmithKline plc, Kaken Pharmaceutical Co., Ltd., Brickell Biotech, Inc., Dermira, Inc., Revance Therapeutics, Inc., Avanor Healthcare Ltd., Ulthera, Inc., and Dr. August Wolff GmbH
Global Hyperhidrosis Treatment Market Taxonomy
By Drug Class
By Route of Administration
By Distribution Channel
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.